The biopharma industry saw numerous deal terminations in 2020. Clinical and regulatory results, change in control limitations, and strategic reprioritizations were among the most common reasons for deal termination. Sanofi […]readmore
Tags : Palatin Technologies
Regulatory
Palatin Technologies’ Vyleesi (bremelanotide injection) Receives FDA’s Approval for Premenopausal
Shots: Vyleesi (SC) is a pre-filled autoinjector pen used in anticipation of a sexual encounter melanocortin receptor agonist, approved for premenopausal women experiencing distress or interpersonal difficulty due to low […]readmore